High Fermentation Titer
Removing feedback inhibition on both PheA and AroG ensures a fast, continuous acid production rate and high final yield.
Phenylalanine (Phe) is an essential aromatic amino acid (AAA) widely used in the pharmaceutical industry (e.g., precursors to Aspartame) and as a nutritional supplement. Industrial production via microbial fermentation, commonly using Escherichia coli (E. coli), is often hampered by a low acid production rate in fermentation . This is primarily due to the stringent feedback inhibition of Phe on its own biosynthetic enzymes. Furthermore, alternative methods like chemical synthesis are highly criticized for the high pollution generated from toxic solvents, heavy metal catalysts, and complex purification steps, making biosynthesis the preferred sustainable route.
CD Biosynsis offers a synthetic biology service focused on engineering E. coli for high-titer L-Phenylalanine production. Our core strategy involves modification of phenylalanine synthase in Escherichia coli . The key enzyme is Chorismate Mutase (CM)/Prephenate Dehydratase (PD) , which is part of the PheA enzyme complex (often referred to as Phenylalanine Synthase). CM is the rate-limiting step and is strongly inhibited by Phe. We use site-directed mutagenesis to create a feedback-resistant PheA variant (PheA ^mut) , ensuring the conversion remains active at high product concentrations. This is coupled with the optimization of shikimate pathway . Phe synthesis starts with the Shikimate Pathway (SP) generating Chorismate. We enhance the flux into SP by overexpressing DAHP Synthase (AroG or AroF variants) , which is the first committed and highly regulated enzyme in the SP. We also block competing pathways (e.g., Tryptophan and Tyrosine branches) to ensure maximum carbon flow is routed to Phe. This integrated strategy removes the metabolic brake (inhibition) and maximizes precursor availability, solving the low production rate problem and providing a sustainable alternative to high pollution chemical synthesis .
Get a QuoteAchieving cost-effective, sustainable Phenylalanine production faces these key challenges:
A successful solution must neutralize key enzymatic inhibition sites and boost precursor supply from the SP.
CD Biosynsis utilizes advanced metabolic engineering to optimize Phenylalanine production in E. coli:
Modification of Phenylalanine Synthase in E. coli
We mutate the PheA complex (CM/PD) to create a feedback-resistant PheA ^mut variant , allowing production to continue at high Phe concentrations.
Optimization of Shikimate Pathway
We overexpress feedback-resistant DAHP Synthase (AroG ^mut or AroF ^mut) to maximize carbon flux into the SP and Chorismate pool.
Competing AAA Pathway Blockade
We delete TyrA and TrpE to block the synthesis of Tyrosine and Tryptophan, directing all Chorismate toward Phenylalanine.
Efflux Pump Overexpression
We overexpress an AAA efflux system (e.g., AroP variants) to enhance Phe secretion, reducing internal toxicity and aiding yield.
This systematic approach overcomes multiple regulatory bottlenecks, maximizes precursor availability, and provides a sustainable production route.
Our Phenylalanine engineering service is dedicated to pursuing the following production goals:
High Fermentation Titer
Removing feedback inhibition on both PheA and AroG ensures a fast, continuous acid production rate and high final yield.
Reduced Environmental Pollution
Biosynthesis entirely avoids the use of toxic chemicals and heavy metals from conventional chemical synthesis, offering a green, low pollution alternative.
High L-Phenylalanine Purity Icon
The engineered microbial pathway produces only the biologically active L-isomer , eliminating the need for complex racemic separation.
Economically Competitive Yield Icon
Optimized flux and high productivity lower manufacturing costs, making the biosynthetic product competitive with existing methods .
E. coli Platform Robustness Icon
Uses a well-characterized, robust, and scalable E. coli host for industrial fermentation.
We provide a sustainable, high-yield, and cost-effective manufacturing platform for L-Phenylalanine.
Our Phenylalanine strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and pathway efficiency.
Explore the potential for a cost-competitive, sustainable L-Phenylalanine supply. CD Biosynsis provides customized strain and pathway engineering solutions:
Why does Phe fermentation have a low production rate?
The Phe pathway is subject to strong feedback inhibition by the final product (Phe) on two key enzymes: PheA (which is the Phenylalanine Synthase complex) and AroG (the first committed enzyme in the Shikimate Pathway). These regulatory brakes slow down production dramatically as Phe accumulates.
How does biosynthesis address the high pollution challenge?
Biosynthesis uses microbial fermentation, replacing toxic chemical reagents and heavy metal catalysts with glucose (or another sugar) and a GRAS host (E. coli). This results in a drastically cleaner process with significantly less toxic waste, solving the high pollution issue.
What is the importance of Shikimate Pathway optimization?
The Shikimate Pathway produces Chorismate, the direct precursor to all three AAAs (Phe, Tyr, Trp). Optimizing SP flux, especially by using a feedback-resistant AroG , ensures a maximized supply of the precursor, supporting a high final Phe yield.
What is the role of deleting TyrA and TrpE?
TyrA and TrpE catalyze the conversion of Chorismate into Tyrosine and Tryptophan, respectively. Deleting these genes ensures that almost all Chorismate is forcibly channeled down the desired Phenylalanine branch, maximizing product specificity and yield.
What is the estimated project timeline?
A project involving dual enzyme mutagenesis (PheA ^mut and AroG ^mut), pathway deletion, and metabolic optimization typically requires 22-26 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.